Establishment Labs Holdings Inc. (ESTA) News
Filter ESTA News Items
ESTA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ESTA News Highlights
- ESTA's 30 day story count now stands at 5.
- Over the past 12 days, the trend for ESTA's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- NOTE are the most mentioned tickers in articles about ESTA.
Latest ESTA News From Around the Web
Below are the latest news stories about ESTABLISHMENT LABS HOLDINGS INC that investors may wish to consider to help them evaluate ESTA as an investment opportunity.
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q4 2022 Earnings Call TranscriptEstablishment Labs Holdings Inc. (NASDAQ:ESTA) Q4 2022 Earnings Call Transcript February 27, 2023 Operator: Greetings, and welcome to the Establishment Labs Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. Please note, this conference is being recorded. I will […] |
Establishment Labs Holdings Full Year 2022 Earnings: EPS Beats ExpectationsEstablishment Labs Holdings ( NASDAQ:ESTA ) Full Year 2022 Results Key Financial Results Revenue: US$161.7m (up 28... |
Establishment Labs to Present at the Cowen 43rd Annual Health Care ConferenceNEW YORK, February 28, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, 2023, at 9:50 am Eastern Time. |
Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial ResultsNEW YORK, February 27, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted the fourth and final module of its modular submission to the FDA for premarket approval of Motiva Implants® in the United States. The company also provided unaudited financial results for the fourth quarter and full year ended December 31, 202 |
Does Establishment Labs Holdings Inc. (ESTA) Have the Potential to Rally 43.03% as Wall Street Analysts Expect?The average of price targets set by Wall Street analysts indicates a potential upside of 43% in Establishment Labs Holdings Inc. (ESTA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
Establishment Labs Holdings' (NASDAQ:ESTA) investors will be pleased with their stellar 176% return over the last three yearsIt might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes... |
Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27SANTA BARBARA, Calif., February 13, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2022, after the market closes on Monday, February 27, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results. |
Wall Street Analysts Predict a 42.71% Upside in Establishment Labs Holdings Inc. (ESTA): Here's What You Should KnowThe mean of analysts' price targets for Establishment Labs Holdings Inc. (ESTA) points to a 42.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022SANTA BARBARA, Calif., January 09, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced preliminary unaudited revenue for the three months and fiscal year ended December 31, 2022. |
Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™SANTA BARBARA, Calif., January 03, 2023--Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into an agreement with Seishin Plastic and Aesthetic Surgery Clinic in Japan for Mia Femtech™ ("Mia®"). |